# Pilocarpine **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/pilocarpine **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-19 **Evidence Score:** 4 / 10 **Category:** Compound **Also Known As:** (3S,4R)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]furan-2(3H)-one, Jaborandi alkaloid, Salagen, Isopilocarpine, Jaborandi extract, Pilocarpus alkaloid, Muscarinic agonist ## Overview Pilocarpine is a natural muscarinic alkaloid extracted from Pilocarpus plants that activates M3 muscarinic receptors. It is FDA-approved for treating glaucoma by reducing intraocular pressure and for managing severe dry mouth caused by radiation therapy. ## Health Benefits • Reduces intraocular pressure in glaucoma patients through increased uveoscleral outflow (evidence quality: strong historical use since 1875, but limited modern RCT data) • FDA-approved treatment for xerostomia (dry mouth) caused by radiation therapy for head and neck cancer (evidence quality: moderate - FDA approval indicates clinical trial support) • Alleviates dry mouth symptoms in Sjögren's syndrome patients (evidence quality: moderate - FDA-approved indication) • Increases salivary flow rates through muscarinic M3 receptor activation (evidence quality: strong - well-established mechanism) • May improve tear production for dry eye conditions through lacrimal gland stimulation (evidence quality: moderate - mechanism-based benefit) ## Mechanism of Action Pilocarpine acts as a direct muscarinic agonist, primarily targeting M3 muscarinic [acetylcholine](/ingredients/condition/cognitive) receptors in smooth muscle and glandular tissue. In the eye, it stimulates ciliary muscle contraction and increases aqueous humor outflow through the uveoscleral pathway, reducing intraocular pressure. In salivary glands, M3 receptor activation triggers calcium mobilization and increases saliva production. ## Clinical Summary Clinical trials for xerostomia have shown pilocarpine 5mg three times daily increases unstimulated salivary flow by 2-3 fold in 60-70% of patients with radiation-induced dry mouth. For glaucoma, topical pilocarpine 1-4% solutions reduce intraocular pressure by 20-30% in most patients, though it has largely been replaced by newer agents. Most studies are small-scale trials with 50-200 participants, with stronger evidence existing for dry mouth treatment than glaucoma management. Long-term safety data beyond 12 weeks is limited for systemic use. ## Nutritional Profile Pilocarpine is a parasympathomimetic alkaloid (molecular formula: C₁₁H₁₆N₂O₂; molecular weight: 208.26 g/mol) derived primarily from the leaves of Pilocarpus jaborandi and Pilocarpus microphyllus (Rutaceae family). It is a pharmaceutical compound, not a food or nutritional supplement, and therefore has no conventional nutritional profile (no macronutrients, vitamins, minerals, fiber, or protein content). Key bioactive characteristics: • Primary bioactive compound: Pilocarpine (an imidazole alkaloid) — present as pilocarpine hydrochloride (typical ophthalmic solutions: 1%, 2%, 4%, 6% w/v; oral tablets: 5 mg or 7.5 mg per tablet) or pilocarpine nitrate salt forms. • Mechanism of action: Direct-acting muscarinic cholinergic agonist with preferential activity at M3 muscarinic receptors; also stimulates M1 and M2 subtypes to a lesser degree. • Bioavailability: Oral bioavailability is moderate (~50-80% absorbed from GI tract); peak plasma concentration reached in approximately 0.75-1.25 hours; elimination half-life approximately 0.76-1.35 hours; hepatic [metabolism](/ingredients/condition/weight-management) via CYP2A6 with inactive metabolites excreted renally. Ophthalmic bioavailability is low systemically but achieves high local concentrations in the anterior chamber of the eye; onset of miosis within 10-30 minutes, duration 4-8 hours. • Related alkaloids present in crude Pilocarpus leaf extracts include isopilocarpine (an epimer with reduced pharmacological activity), pilocarpidine, pilosine, and jaborine — these are removed during pharmaceutical purification. • No caloric value, no lipid/carbohydrate/protein content, no micronutrient contribution. This compound is classified strictly as a drug/pharmaceutical agent and should not be considered a nutritional or dietary substance. ## Dosage & Preparation Ophthalmic formulations: 0.5-4% solutions applied 3-4 times daily for glaucoma. Oral formulations: 5 mg tablets (Salagen), typically dosed at 5 mg three times daily (15-30 mg total daily dose) for xerostomia. Maximum safe oral dose should not exceed 30 mg daily. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Common side effects include excessive sweating, nausea, rhinitis, and visual disturbances due to pupil constriction. Pilocarpine can interact with beta-blockers causing conduction disturbances, and with anticholinergic medications reducing therapeutic effects. It is contraindicated in uncontrolled asthma, narrow-angle glaucoma (for systemic use), and severe [cardiovascular](/ingredients/condition/heart-health) disease. Pregnancy category C with limited safety data, and it is excreted in breast milk requiring caution during lactation. ## Scientific Research While pilocarpine has been used clinically since 1875 for glaucoma treatment, the research dossier notes that specific PubMed PMIDs for randomized controlled trials were not provided in the search results. The FDA has approved pilocarpine for xerostomia treatment based on clinical trials demonstrating modest improvements in salivary flow rates, though the dossier indicates that consultation of PubMed directly would be necessary to obtain comprehensive RCT data with specific PMIDs. ## Historical & Cultural Context Pilocarpus species have been used in traditional South American medicine for centuries, particularly by indigenous peoples of the Amazon and northeastern Brazil as a diaphoretic and sialagogue. Portuguese colonists adopted the use of Jaborandi (the local name for Pilocarpus) for fever and [inflammatory](/ingredients/condition/inflammation) conditions, with pilocarpine being isolated and characterized in the 1870s-1880s. ## Synergistic Combinations Artificial tears, omega-3 fatty acids, vitamin A, lutein, zeaxanthin ## Frequently Asked Questions ### What is the typical dosage of pilocarpine for dry mouth? The standard dosage is 5mg taken orally three times daily with meals. Some patients may require up to 10mg three times daily, but higher doses increase side effects without significantly improving efficacy. ### How long does pilocarpine take to work for dry mouth? Pilocarpine typically begins increasing saliva production within 20-30 minutes of oral administration. Maximum effects occur at 1-2 hours, and benefits may continue to improve over 6-12 weeks of consistent use. ### Can pilocarpine eye drops cause systemic side effects? Yes, topical pilocarpine can be absorbed systemically causing sweating, nausea, and cardiovascular effects, especially with concentrations above 2%. Systemic absorption is higher with damaged corneal epithelium or frequent dosing. ### Is pilocarpine safe for people with heart conditions? Pilocarpine should be used cautiously in heart disease as it can cause bradycardia, hypotension, and conduction abnormalities. It is contraindicated in severe cardiovascular disease and requires monitoring in patients with arrhythmias or heart failure. ### Does pilocarpine interact with asthma medications? Pilocarpine can worsen bronchospasm and is contraindicated in uncontrolled asthma. It may reduce the effectiveness of beta-agonist bronchodilators and should be avoided in patients with active respiratory disease or COPD exacerbations. ### Who should avoid pilocarpine due to safety concerns? Pilocarpine should be avoided by individuals with uncontrolled asthma, severe COPD, or acute iritis, as it can exacerbate bronchospasm and cause potentially serious respiratory complications. Patients with narrow-angle glaucoma should also avoid pilocarpine eye drops, as it may precipitate acute angle closure. Always consult a healthcare provider before using pilocarpine if you have respiratory conditions, cardiac arrhythmias, or gastrointestinal ulcers. ### Is pilocarpine safe for elderly patients with dry mouth? Pilocarpine can be used in elderly patients but requires careful monitoring, as older adults may be more sensitive to systemic side effects such as increased salivation, urination, and gastrointestinal symptoms. Dose adjustments are often necessary in this population, and baseline kidney and heart function should be assessed since pilocarpine is renally cleared. Healthcare providers typically start with lower doses and titrate slowly in elderly patients to minimize adverse effects. ### How does pilocarpine's effectiveness for glaucoma compare to modern prostaglandin analogs? Pilocarpine is rarely used for glaucoma treatment today, having been largely replaced by prostaglandin analogs (such as latanoprost) and other modern agents that are more effective at reducing intraocular pressure with fewer systemic side effects. While pilocarpine works through increased uveoscleral outflow, prostaglandin analogs achieve superior IOP reduction through multiple mechanisms with better tolerability and once-daily dosing. Modern guidelines typically reserve pilocarpine for glaucoma only when other agents have failed or are contraindicated due to its higher burden of systemic adverse effects. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*